FTC suspends challenge to Amgen-Horizon Therapeutics deal

FTC suspends challenge to Amgen-Horizon Therapeutics deal

<ul><li> </li><li> </li></ul> The Federal Trade Commission is suspending its challenge to Amgen's (AMGN) $27.8 billion bid to acquire Horizon Therapeutics (HZNP). The FTC is concerned Amgen will b… [+297 chars]

Read More
Top